SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-12-319329
Filing Date
2012-07-27
Accepted
2012-07-27 15:25:03
Documents
4
Period of Report
2012-08-31
Effectiveness Date
2012-07-27

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d367875ddef14a.htm DEF 14A 1262897
2 GRAPHIC g367875g12c39.jpg GRAPHIC 9412
3 GRAPHIC g367875g37r97.jpg GRAPHIC 10333
4 GRAPHIC g367875g97z57.jpg GRAPHIC 7065
  Complete submission text file 0001193125-12-319329.txt   1301332
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-12465 | Film No.: 12990502
SIC: 2834 Pharmaceutical Preparations